Everything you care about in one place
Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.
Get Feederema.europa.eu
What's new
Get the latest updates from What's new directly as they happen.
Follow now 267 followers
Latest posts
Last updated about 11 hours ago
Human medicines European public assessment report (EPAR): Lydisilka, estetrol,drospirenone, Date of authorisation: 19/05/2021, Revision: 7, Status: Authorised
about 11 hours ago
Human medicines European public assessment report (EPAR): Lydisilka, estetrol,drospirenone, Date of authorisation...
Human medicines European public assessment report (EPAR): Vimpat, lacosamide, Date of authorisation: 29/08/2008, Revision: 53, Status: Authorised
about 11 hours ago
Human medicines European public assessment report (EPAR): Vimpat, lacosamide, Date of authorisation...
Human medicines European public assessment report (EPAR): Ontilyv, opicapone, Date of authorisation: 21/02/2022, Revision: 2, Status: Lapsed
about 11 hours ago
Human medicines European public assessment report (EPAR): Ontilyv, opicapone, Date of authorisation...
Human medicines European public assessment report (EPAR): Kevzara, sarilumab, Date of authorisation: 23/06/2017, Revision: 15, Status: Authorised
about 12 hours ago
Human medicines European public assessment report (EPAR): Kevzara, sarilumab, Date of authorisation...
Human medicines European public assessment report (EPAR): Ofev, nintedanib, Date of authorisation: 14/01/2015, Revision: 28, Status: Authorised
about 12 hours ago
Human medicines European public assessment report (EPAR): Ofev, nintedanib, Date of authorisation...
Human medicines European public assessment report (EPAR): Incruse Ellipta (previously Incruse), umeclidinium bromide, Date of authorisation: 28/04/2014, Revision: 21, Status: Authorised
about 13 hours ago
Human medicines European public assessment report (EPAR): Incruse Ellipta (previously Incruse), umeclidinium...
Human medicines European public assessment report (EPAR): Nexavar, sorafenib, Date of authorisation: 19/07/2006, Revision: 35, Status: Authorised
about 13 hours ago
Human medicines European public assessment report (EPAR): Nexavar, sorafenib, Date of authorisation...
Human medicines European public assessment report (EPAR): Winrevair, Sotatercept, Date of authorisation: 22/08/2024, Revision: 1, Status: Authorised
about 13 hours ago
Human medicines European public assessment report (EPAR): Winrevair, Sotatercept, Date of authorisation...
EMA’s 30th anniversary scientific conference - Medicines, regulation and the future, European Medicines Agency, Amsterdam, the Netherlands, Broadcast, from 25 June 2025, 10:00 (CEST) to 25 June 2025, 16:00 (CEST)
about 13 hours ago
EMA’s 30th anniversary scientific conference - Medicines, regulation and the future, European...
Human medicines European public assessment report (EPAR): Rolufta Ellipta (previously Rolufta), umeclidinium, Date of authorisation: 20/03/2017, Revision: 14, Status: Authorised
about 14 hours ago
Human medicines European public assessment report (EPAR): Rolufta Ellipta (previously Rolufta), umeclidinium...
Day 80 assessment report - Non-clinical template with guidance Rev. 03.25 - Revamp
about 15 hours ago
Day 80 assessment report - Non-clinical template with guidance Rev. 03.25 -...